Stay updated on KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added a new 'Study Status' entry on 2026-03-25 and version 9 on 2026-03-23. Deleted the 2025-05-29 entry.
    Difference
    0.4%
    Check dated 2026-04-01T17:15:40.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Added revision: v3.5.0; removed revision: v3.4.3 from the record history.
    Difference
    0.1%
    Check dated 2026-03-25T07:26:49.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the Record History.
    Difference
    0.1%
    Check dated 2026-03-10T14:34:33.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    Added revision entry v3.4.2 and removed v3.4.1 from the Record History page, updating the displayed site version history.
    Difference
    0.1%
    Check dated 2026-02-17T03:23:23.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    Added a new revision entry (v3.4.1) to the record history and removed a funding-status notice along with an older revision (v3.4.0). These are administrative updates to the page's history and do not affect the underlying study data or public-facing trial information.
    Difference
    0.8%
    Check dated 2026-02-09T22:04:15.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    A site-wide notice about government funding and operating status was added at the top of the page, but the study record content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-02T20:17:44.000Z thumbnail image

Stay in the know with updates to KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the KN035: Pembrolizumab in Advanced Solid Tumors Clinical Trial page.